tirzepatide and liver function is a GIP & GLP1 receptor agonist., #tirzepatide #tirzepatideweightloss #tirzepitide #medicaleducation #endocrinology A Rare Case of Tirzepatide-Induced

The 4 mg dose produced 11% weight loss, still clinically meaningful but notably lower than the maximum dose

In consultation with the clinical experts, no major concern with the generalizability of results due to this difference was identified

Also seek prompt medical attention for right upper abdominal pain, fever, or yellowing of the skin/eyes, which may suggest gallbladder problems

However, availability and insurance coverage for Mounjaro are currently limited

Discontinue the DPP-4 inhibitor when initiating a GLP-1 RA

Another protective mechanism exerted by exenatide on the endothelium is through its action through opening the KATP channels thus protecting against impairment in endothelium-dependent vasodilatation induced by ischemiareperfusion (IR) injury [64]